CD274 (Atezolizumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7607798

The Humanized Monoclonal anti-CD274 (Atezolizumab Biosimilar) antibody has been validated for FACS and ELISA. It is suitable to detect CD274 (Atezolizumab Biosimilar) in samples from Human.

Quick Overview for CD274 (Atezolizumab Biosimilar) antibody (Biotin) (ABIN7607798)

Target: CD274 (Atezolizumab Biosimilar)

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CD274 (Atezolizumab Biosimilar) antibody is conjugated to Biotin

Application: Flow Cytometry (FACS), ELISA

Product Details anti-CD274 (Atezolizumab Biosimilar) Antibody (Biotin)

Purpose: Biotinylated Anti-PDL1 (atezolizumab biosimilar) mAb

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Target Details for CD274 (Atezolizumab Biosimilar)

Target: CD274 (Atezolizumab Biosimilar)

Alternative Name: atezolizumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:PD-L1,CD274,B7-H1,PDCD1L1,PDCD1LG1
Synonyms Antibody:MPDL3280A,RG7446